A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer
Clinical trial NCT03258398 · COMPLETED
Trial details
- NCT number
- NCT03258398
- Sponsor
- Effector Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2019-03-26
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.